Gujarat, India
Testing Research Laboratory
Joint Venture With Sotax
Conceptual Laboratory Design
Detailed Engineering Drawing
Turnkey Execution
Clean Room Partition
Office Glass Partition
Modular Ceiling
Bio-Safety Cabinet
Laboratory Furniture
Anti Vibration Table
Fume Hoods
Ortiv – Q3 which is a joint venture with SOTAX Pharma is a leading Research laboratory Company having expertise and knowledge to assist global pharmaceutical companies with their dissolution and release testing needs for different dosage forms. Company is expert in vitro dissolution testing and can find the best method for various products, such as APIs, tablets, implants, semi solids, and many other products.
Dr. Mukesh Kumar and Ashish Gupta are experienced professionals leading Ortiv with vast experience in pharmaceutical development. Dr. Kumar specializes in injectable and ophthalmic dosage forms, reverse engineering, and formulation scale-up for regulated markets. Ashish Gupta brings extensive expertise in Analytical R&D, focusing on complex formulations, method development, and validation. Their combined knowledge drives Ortiv’s success in delivering cutting-edge, value-added services to clients across global markets.
Ortiv-Q3 is recognised for its extensive expertise in pharmaceutical services, providing advanced solutions in API screening, solubility studies, and method development. Their capabilities span in-vitro release testing (IVRT), in-vitro permeation testing (IVPT), Q3 characterization, and IVIVC modeling, crucial for formulation development and bioequivalency assessments. Additionally, Ortiv excels in reverse engineering, analytical method automation, and cleaning validation, supporting the development and approval of complex pharmaceutical products for regulated markets.
Further the founders wanted to offer customers Formulation & Development services so they decided to expand their lab by leasing the additional space on the same floor. As Ortiv-Q3 is a small to midsize organisation they decided to do the Turnkey approach for the upcoming lab. For which Brinda Pharma Technologies was invited to participate. Brinda Pharma Technologies worked with the founders when they were in their previous organisation to build the lab. So we were the preferred participant to do the lab expansion project.
Dr. Mukesh Kumar & Mr. Ashish Gupta
Founders
Ortiv-Q3 appointed an External Consultant Mr. RJ Shah, He has a rich experience in consulting various pharmaceutical companies in the industry. Whether it’s a greenfield or a brownfield project he can guide companies to the achieve the specific goals.
Mr. RJ Shah shared the conceptual design of the laboratory by utilising the available space and keeping the regulations in mind. Brinda Pharma Technologies did the detailed design of the entire lab for the execution. After finalisation of design and key requirements we submitted the Turnkey Proposal for the entire laboratory. Brinda Pharma Technologies worked closely with the consultant to turn the founder’s vision into a reality.
As we previously mentioned Dhanuka is heavily investing on R&D to improve existing products and make new products.
To build such a modern R&D lab, the company began its activities to find a space in order to accommodate new R&D lab. Brinda Pharma Technologies were invited to discuss the project.
Brinda Pharma Technologies has been partner of Dhanuka in building laboratories for a long time. Brinda Pharma Technologies has previously built the state of the art QC lab for Dhanuka in its Dahej Plant which is also company’s largest plant till date.
As it was a brownfield project, so many things has to in consideration like existing setup, space, as well as retro fitting existing setup into new one to minimise the costs and better sustainability.
Brinda Pharma Technologies started the project by making the list of available items which can be used in the expansion and further aligned the same in the design along with new products. The detailed designing was a key part in order to build the laboratory.
Dr. Mukesh Kumar
Founder
Brinda Pharma Technologies completed the project by turning the founder’s vision into the reality. Working closely with a consultant appointed by Ortiv-Q3, we prepared a detailed engineering drawing. Throughout the process, Brinda Pharma Technologies had Single Point of Contact (SPoC) approach for effective communication with client.
Ortiv-Q3’s project successfully delivers comprehensive solutions for pharmaceutical formulation and development. By integrating advanced laboratory design, expert engineering, and turnkey execution, Ortiv ensures that every aspect of the new facility meets the highest industry standards.
We at Brinda Pharma Technologies build labs for every purpose and every industry.
We deliver a lab that fits your vision, operational goals, and budget.
Let’s get started on building a high-performing laboratory that sets a benchmark in quality and innovation.
We will quickly setup a call or meeting to understand your requirements.
